Docetaxel and Gemcitabine administered on days 1 and 8 for metastatic non-small cell lung carcinoma (NSCLC): a phase II multicenter trial.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples